Qiagen N.V.
QGEN- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001015820
No open-market purchases or sales by Qiagen N.V. insiders were filed in the last 90 days; 337 institutions reported holding it in 13F filings for Q2 2026, worth $5.68B in total; no superinvestor holds it.
Holders of 5% or more of QGEN
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Qiagen N.V., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Massachusetts Financial Services Co | 13G/A | 11.60%25.3M shares | – | May 14, 20251 filing | May 14, 2025 | SEC |
| Wellington Management Group LLP | 13G/A | 10.70%23.3M shares | −1.30 ppfrom 12.00% | Feb 6, 20253 filings | Nov 12, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
4 Schedule 13D and 13G filings on Qiagen N.V., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Nov 12, 20259:33 AM ET | Wellington Management Group LLPand 3 others | 13G/A | 10.70%23.3M shares | −1.30 ppfrom 12.00% | Sep 30, 2025 | SEC |
| Aug 12, 202510:34 AM ET | Wellington Management Group LLPand 3 others | 13G/A | 12.00%26.0M shares | +1.30 ppfrom 10.70% | Jun 30, 2025 | SEC |
| May 14, 20253:03 PM ET | Massachusetts Financial Services Co | 13G/A | 11.60%25.3M shares | – | Mar 31, 2025 | SEC |
| Feb 6, 20259:38 AM ET | Wellington Management Group LLPand 3 others | 13G | 10.70%23.3M shares | New | Jan 31, 2025 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Qiagen N.V. shares.
No Form 144 notices for Qiagen N.V. are on file.